BIOLIFE SOLUTIONS ($BLFS) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of $0.04 per share, beating estimates of -$0.05 by $0.09. The company also reported revenue of $23,940,000, beating estimates of $22,665,644 by $1,274,356.
You can see Quiver Quantitative's $BLFS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOLIFE SOLUTIONS Insider Trading Activity
BIOLIFE SOLUTIONS insiders have traded $BLFS stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.
Here’s a breakdown of recent trading of $BLFS stock by insiders over the last 6 months:
- ABY J. MATHEW (EVP & Chief Scientific Officer) has made 0 purchases and 13 sales selling 77,726 shares for an estimated $1,781,288.
- TROY WICHTERMAN (Chief Financial Officer) has made 0 purchases and 8 sales selling 33,304 shares for an estimated $771,930.
- SARAH AEBERSOLD (Chief Human Resources Officer) has made 0 purchases and 10 sales selling 23,516 shares for an estimated $585,315.
- TODD BERARD (Chief Marketing Officer) has made 0 purchases and 8 sales selling 12,112 shares for an estimated $282,319.
- KAREN A. FOSTER (Chief Quality and Operations) has made 0 purchases and 8 sales selling 10,534 shares for an estimated $245,112.
- AMY DUROSS sold 5,632 shares for an estimated $140,574
- SEAN WERNER (Chief Technology Officer) has made 0 purchases and 2 sales selling 224 shares for an estimated $5,577.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIOLIFE SOLUTIONS Hedge Fund Activity
We have seen 81 institutional investors add shares of BIOLIFE SOLUTIONS stock to their portfolio, and 96 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. added 428,099 shares (+inf%) to their portfolio in Q4 2024, for an estimated $11,113,450
- MILLENNIUM MANAGEMENT LLC added 377,111 shares (+49.1%) to their portfolio in Q4 2024, for an estimated $9,789,801
- UBS GROUP AG added 318,002 shares (+2130.0%) to their portfolio in Q4 2024, for an estimated $8,255,331
- PORTOLAN CAPITAL MANAGEMENT, LLC removed 290,577 shares (-67.9%) from their portfolio in Q4 2024, for an estimated $7,543,378
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 239,100 shares (-20.8%) from their portfolio in Q4 2024, for an estimated $6,207,036
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 236,267 shares (+40.4%) to their portfolio in Q4 2024, for an estimated $6,133,491
- VICTORY CAPITAL MANAGEMENT INC removed 218,962 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $5,001,092
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIOLIFE SOLUTIONS Analyst Ratings
Wall Street analysts have issued reports on $BLFS in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 03/05/2025
- Stephens issued a "Overweight" rating on 11/15/2024
- Cowen & Co. issued a "Buy" rating on 11/13/2024
To track analyst ratings and price targets for BIOLIFE SOLUTIONS, check out Quiver Quantitative's $BLFS forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
